CLINICAL TRIAL

matrix
contact-width-matrix
corrola-matrix

first human Implantation

In 2017, Corassist Completed Its First-In-Human (FIH) Stand-Alone Implantation.

The Corolla® TAA Intra-Ventricular Device Was Implanted In A Patient In Israel (RAMBAM). The Patient Showed Subjective Clinical Improvement In LV Diastolic And Systolic Functioning.

HF Hospitalization throughout disease progression

Without CORolla
With CORolla

Chronic decline

Repeated Hospitalizations Fail To Counter Disease Decline

without corrola
  • Hospitalization Acute Decompensations

1Progression Stage

back to life

Improvement In Cardiac Function After Corolla® Implantation

with corrola
  • Hospitalization Acute Decompensations
  • Device Implantation

1Progression Stage

Currently Recruiting Patients for the CORolla® Clinical Trial

location-icon

RAMBAM Health Care Campus

Please Contact Dr. Anastasia Weis
+97247772048
Read More
contact-width-matrix
contact-matrix

Contact Us

    CorAssist Cardiovascular Ltd.
    57 Derech Ha’atzmaut,
    PO Box 33066,
    Haifa 3303329, Israel

    +972-52-638-4750 gideon@corassist.com
    © Corassist Cardiovascular Ltd. All rights reserved
    Site by Imaginet